Latest: Abzena Launches EpiScreen® 2.0 Immunogenicity Platform | Learn more
- About
- Main Menu
- Main Menu
- Leadership Team
- Our History
- Locations
- Capabilities
- Main Menu
- Main Menu
- Bioconjugates & Chemistry
- Biologics
- Resources
- Careers
- Contact
Abzena is proud to be the lead partner for World ADC Asia 2024, which will take place in Incheon, South Korea, on June 25–27.
Don’t miss our talk on Day 1 at 9:30 AM given by Petra Dieterich, PhD.
Schedule a meeting below with Ji-won Chio, Senior Director, Client Engagement, or Jonathan Cruickshank, Head of EU/ROW Sales, to learn how utilizing our expertise in identifying and mapping the appropriate design space for the development of your complex Antibody Drug Conjugates (ADC) can accelerate lead drug candidate selection, as well as how we can identify and de-risk your clinical candidates for development and ensure stage-specific milestones are met through our developability assessments.
Event Information:
Incheon, South Korea
June 25-27, 2024